We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
23andMe and The Parkinson's Institute and Clinical Center Announces Research Initiative
News

23andMe and The Parkinson's Institute and Clinical Center Announces Research Initiative

23andMe and The Parkinson's Institute and Clinical Center Announces Research Initiative
News

23andMe and The Parkinson's Institute and Clinical Center Announces Research Initiative

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "23andMe and The Parkinson's Institute and Clinical Center Announces Research Initiative"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

23andMe and The Parkinson's Institute and Clinical Center (Parkinson's Institute) have announced a research initiative under which Parkinson's Institute patients, with financial support from The Michael J. Fox Foundation, will enroll in the 23andMe Personal Genome Service™ to support the development of advanced methods for clinical and epidemiologic research for Parkinson's disease.

The new research initiative is designed to improve current methods of collecting information for Parkinson's research by leveraging the internet to expand the involvement of Parkinson's patients in clinical research and increase the frequency and quality of patient data collection.

Together, 23andMe and the Parkinson's Institute will design and validate web-based clinical assessment tools that can be administered to online communities.

23andMe will establish a social networking platform to facilitate the development of communities and research projects based on common traits of Parkinson's disease patients.

All participating Parkinson's Institute patients will be enrolled in the 23andMe Personal Genome Service™ and will provide a saliva sample for a comprehensive genome scan generating more than 580,000 data points per patient.

Parkinson's Institute patients will provide specific information and insights that will include their individual environmental exposures, family history, disease progression and treatment response.

Patients' risk factor and clinical data collected through the newly developed and validated web-based tools will then be merged with their genetic data to conduct research on Parkinson's disease.

New surveys will be developed and administered to the growing cohort of patients, generating new risk factor and clinical data for comparison with the existing genetic data.

“This partnership represents the basis for ‘Research 2.0’, a new research architecture that web-enables validated diagnostic procedures and combines them with genetic profiles of Parkinson's patients,” said Linda Avey, co-founder of 23andMe.

“By building a social network for the Parkinson's disease community, and combining it with the world-class expertise of Parkinson's Institute researchers, we hope to establish an entirely new paradigm for how genetic research is conducted that actively involves the patient.”

Advertisement